Serum amyloid A-1 protein (SAA1)

Glaucoma/ocular hypertension

Glucocorticoid receptor (NR3C1)

Glaucoma/ocular hypertension

Adrenergic beta-2 receptor (ADRB2)

Glaucoma/ocular hypertension

Adrenergic beta-2 receptor (ADRB2)

Glaucoma/ocular hypertension

Brain-derived neurotrophic factor (BDNF)

Glaucoma/ocular hypertension

Matrix metalloproteinase-9 (MMP-9)

Glaucoma/ocular hypertension

Myocilin (MYOC)

Glaucoma/ocular hypertension

Myocilin (MYOC)

Glaucoma/ocular hypertension

Nitric oxide (NO)

Glaucoma/ocular hypertension

Detection of apoptosing retinal cells (DARC)

Glaucoma/ocular hypertension

antibodies against human vimentin and humanglial fi- brillary acid protein (GFAP ), anti-Ro/SS-A (Sjogren syndrome A; also commonly called Ro antigens), serum an ti- bodies that bind to human optic nerve head proteoglycans, including chondroi tin sulfate and heparin, serum autoanti- bodies against gamma-enolase(y-enolase) in retinal ganglion cells of glaucomatous patients and glutathione S-transferas e (GST) antibodies

Glaucoma/ocular hypertension

Bone morphogenetic proteins (BMP)

Glaucoma/ocular hypertension

Citrate

Glaucoma/ocular hypertension

Cytotoxicity

Glaucoma/ocular hypertension

tubulin alpha-1A chain, SAPS domain family member 1, lim and SH3 domain protein 1, synaptosomalassociated protein 23, latent-transforming growth factor beta-bin ding protein, isoform lL, drebrin, proto-oncogene tyrosine-protein kinase Src, t hymosin beta-10, zinc fingerprotein 185, dynamin-1-like protein, protein phosph atase 1 regulatory subunit 12A, platelet endothelial cell adhesion molecule, tra nsgelin-2, AP-2 complex subunit sigma-1 and exportin-7

Glaucoma/ocular hypertension